Press-release for stocks related to therapeutics

Prices are updated after-hours

tags : Therapeutics crawled date : 2022 - 08 - 01

save search

BioXcel Therapeutics Announces NIH NIDA Grant to Columbia University to Support Further Studies of BXCL501 (Sublingual Dexmedetomidine) for Treating Opioid Withdrawal
Published: 2022-08-01 (Crawled : 23:00) - biospace.com/
BTAI | $2.77 8.63% 7.94% 620K

Health Technology

| -82.19% | O: -0.78% H: 1.63% C: -10.05%
bxcl501 opioid grant therapeutics

Avalo Therapeutics Transfers Anti-IL-18 Antibody, AVTX-007 (camoteskimab) to Apollo Therapeutics
Published: 2022-08-01 (Crawled : 23:00) - biospace.com/
AZNCF | News | $138.24 -4.19% 800

Health Technology

| 4.19% | O: 2.39% H: 0.0% C: -0.9%
AVTX | $11.71 -2.5% -2.56% 68K

Manufacturing

| 223.06% | O: 4.72% H: 10.08% C: -4.51%
AZN | News | $68.56 0.29% 0.29% 4.7M

Health Technology

| 3.5% | O: 0.44% H: 0.53% C: -1.31%
il-18 therapeutics

TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-08-01 (Crawled : 22:00) - globenewswire.com
TCRR 4 | $1.48 3.38% 3.9M

Health Technology

| Email alert Add to watchlist
nasdaq grants therapeutics

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-08-01 (Crawled : 22:00) - globenewswire.com
GTHX | $4.12 -1.2% -1.21% 730K

Health Technology

| -49.51% | O: -1.35% H: 5.23% C: 3.36%
nasdaq grants therapeutics

Cara Therapeutics to Announce Second Quarter 2022 Financial Results on August 8, 2022
Published: 2022-08-01 (Crawled : 21:00) - biospace.com/
CARA | $0.6816 -1.22% -1.23% 350K

Health Technology

| -92.45% | O: 1.37% H: 0.0% C: -7.0%
therapeutics results

Arcturus Therapeutics to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 9, 2022
Published: 2022-08-01 (Crawled : 21:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -14.93% | O: 0.22% H: 0.0% C: 0.0%
ARCT 4 | $25.995 -1.23% -1.25% 630K

Health Technology

| 48.03% | O: -2.17% H: 7.16% C: 1.75%
report therapeutics update results

DiaMedica Therapeutics to Participate in the BTIG Biotechnology Conference 2022
Published: 2022-08-01 (Crawled : 21:00) - biospace.com/
DMAC | $2.46 -1.21% -1.22% 21K

Health Technology

| 44.85% | O: -1.21% H: 1.17% C: -4.91%
conference therapeutics

Candel Therapeutics Appoints Three New Members to its Board of Directors
Published: 2022-08-01 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -8.16% | O: -3.9% H: 0.0% C: 0.0%
CADL | $5.17 -5.31% -5.61% 520K

| 66.77% | O: 3.23% H: 0.0% C: -4.69%
SIEN | $0.174 0.69% 3.4M

Health Technology

| -97.11% | O: 2.12% H: 29.68% C: 23.24%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -7.36% | O: -1.92% H: 0.0% C: 0.0%
therapeutics

G1 Therapeutics to Participate Virtually in the 2022 BTIG Biotechnology Conference and the 2022 Wedbush Pacgrow Healthcare Conference
Published: 2022-08-01 (Crawled : 13:20) - globenewswire.com
GTHX | $4.12 -1.2% -1.21% 730K

Health Technology

| -50.66% | O: -0.96% H: 5.82% C: -1.33%
conference therapeutics

Cyteir Therapeutics to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference
Published: 2022-08-01 (Crawled : 13:00) - biospace.com/
CYT | $3.02 2.65% 1M

Manufacturing

| 3.78% | O: -6.53% H: 7.72% C: -2.94%
conference therapeutics

Qualigen Therapeutics Reports Positive QN-247 Readout in Triple Negative Breast Cancer in Vivo Model
Published: 2022-08-01 (Crawled : 13:00) - globenewswire.com
QLGN | $0.301 -3.43% -3.55% 30K

Health Technology

| -92.36% | O: 11.39% H: 2.89% C: -11.04%
qn-247 therapeutics readout positive cancer negative

Altamira Therapeutics Completes Interim Sample Size Analysis of COVAMID Trial with Bentrio in Acute COVID-19
Published: 2022-08-01 (Crawled : 13:00) - globenewswire.com
CYTO | $1.5 -7.95% 46K

Manufacturing

| -83.98% | O: 0.0% H: 0.57% C: -5.55%
covid-19 trial therapeutics

Palisade Bio Launches New Corporate Website and Reiterates Commitment to Develop Therapeutics that Protect Intestinal Barrier Health
Published: 2022-08-01 (Crawled : 12:20) - globenewswire.com
PALI | $4.735 -6.61% -7.07% 140K

Manufacturing

| -75.62% | O: 0.93% H: 0.0% C: -0.74%
health therapeutics

Xeris’ Commercialization Partner for Ogluo®, Tetris Pharma Ltd, to Be Acquired by Arecor Therapeutics
Published: 2022-08-01 (Crawled : 12:00) - biospace.com/
XERS | $1.73 -1.7% -1.73% 2M

Health Technology

| 22.54% | O: 0.0% H: 12.68% C: 6.34%
ogluo pharma commercialization therapeutics acquired

Sage Therapeutics to Present at Upcoming August 2022 Investor Conferences
Published: 2022-08-01 (Crawled : 12:00) - biospace.com/
SAGE | $13.35 2.42% 2.36% 1.3M

Health Technology

| -61.26% | O: -0.58% H: 1.52% C: 0.7%
therapeutics

Aileron Therapeutics Is Pleased to Outline Strategy to Strengthen Phase 1b Clinical Trial of ALRN-6924 in Patients with p53-Mutated Breast Cancer
Published: 2022-08-01 (Crawled : 12:00) - globenewswire.com
ALRN | $4.785 -4.3% -4.49% 85K

Health Technology

| 24.67% | O: 5.21% H: 0.0% C: -19.85%
alrn-6924 trial therapeutics cancer phase 2b

Autologous Cell Therapy Market Size to Grow by USD 4.11 billion, Bayer AG and Brainstorm Cell Therapeutics Inc. Among Key Vendors - Technavio
Published: 2022-08-01 (Crawled : 11:00) - prnewswire.com
BCLI A | $0.5384 4.69% 4.48% 1M

Health Technology

| -79.3% | O: 0.78% H: 7.95% C: 5.43%
therapeutics therapy market

Cerevel Therapeutics Reports Second Quarter 2022 Financial Results and Business Updates
Published: 2022-08-01 (Crawled : 11:00) - globenewswire.com
CERE | $42.15 0.02% 0.02% 810K

Finance

| 60.56% | O: -1.48% H: 14.63% C: 6.8%
therapeutics results

Beam Therapeutics Announces FDA Clinical Hold on BEAM-201 IND Application
Published: 2022-08-01 (Crawled : 11:00) - globenewswire.com
BEAM | $23.9 -1.69% -1.72% 4.5M

Health Technology